Financials

News Discussions Technicals Seasonals

338220 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

VUNO, Inc. engages in the development of development of artificial intelligence based medical solutions. It offers diagnostic support decision tools and systems such as bone age assessment tool, chest x-ray, pulmonary lung nodule detection and reporting system, eye fundus screening solution, neuro degenerative disease quantification tool, and cardiac activity warning system. The company was founded by Ye-Ha Lee, Hyun-Jun Kim, and Kyu-Hwan Jung on December 10, 2014 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

338220 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company